These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25659981)

  • 41. FDA Approval of Flibanserin--Treating Hypoactive Sexual Desire Disorder.
    Joffe HV; Chang C; Sewell C; Easley O; Nguyen C; Dunn S; Lehrfeld K; Lee L; Kim MJ; Slagle AF; Beitz J
    N Engl J Med; 2016 Jan; 374(2):101-4. PubMed ID: 26649985
    [No Abstract]   [Full Text] [Related]  

  • 42. Flibanserin Ineffective for Hypoactive Sexual Desire Disorder in Women.
    Shaughnessy AF
    Am Fam Physician; 2016 Sep; 94(5):384-6. PubMed ID: 27583427
    [No Abstract]   [Full Text] [Related]  

  • 43. U.S. Food and Drug Administration Approval of Addyi (Flibanserin) for Treatment of Hypoactive Sexual Desire Disorder.
    Puppo G; Puppo V
    Eur Urol; 2016 Feb; 69(2):379-80. PubMed ID: 26455357
    [No Abstract]   [Full Text] [Related]  

  • 44. Improving prospects for treating hypoactive sexual desire disorder (HSDD): development status of flibanserin.
    Thorp J; Palacios S; Symons J; Simon J; Barbour K
    BJOG; 2014 Oct; 121(11):1328-31. PubMed ID: 24909923
    [No Abstract]   [Full Text] [Related]  

  • 45. Evaluation of safety for flibanserin.
    Clayton AH; Brown L; Kim NN
    Expert Opin Drug Saf; 2020 Jan; 19(1):1-8. PubMed ID: 31855607
    [No Abstract]   [Full Text] [Related]  

  • 46. Hypoactive sexual desire disorder: inventing a disease to sell low libido.
    Meixel A; Yanchar E; Fugh-Berman A
    J Med Ethics; 2015 Oct; 41(10):859-62. PubMed ID: 26124287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The abandonment of the development of flibanserin].
    Nau JY
    Rev Med Suisse; 2010 Oct; 6(268):2044-5. PubMed ID: 21137467
    [No Abstract]   [Full Text] [Related]  

  • 48. [Efficacy and safety of flibanserin "new female Viagra
    Terrier C; Terrier JE
    Prog Urol; 2016; 26(11-12):592-599. PubMed ID: 27663307
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Female sexual dysfunction: Drug treatment options].
    Alcántara Montero A; Sánchez Carnerero CI
    Semergen; 2016; 42(5):e33-7. PubMed ID: 27041639
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systematic Review and Meta-analysis of Flibanserin's Effects and Adverse Events in Women with Hypoactive Sexual Desire Disorder.
    Saadat SH; Kabir A; Rahmani K; Panahi Y; Hosseinialhashemi M; Sahebkar A
    Curr Drug Metab; 2017; 18(1):78-85. PubMed ID: 27784209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women.
    Pfaus JG; Sadiq A; Spana C; Clayton AH
    CNS Spectr; 2022 Jun; 27(3):281-289. PubMed ID: 33455598
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting circuits of sexual desire as a treatment strategy for hypoactive sexual desire disorder.
    Stahl SM
    J Clin Psychiatry; 2010 Jul; 71(7):821-2. PubMed ID: 20667289
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Next-day residual effects of flibanserin on simulated driving performance in premenopausal women.
    Kay GG; Hochadel T; Sicard E; Natarajan KK; Kim NN
    Hum Psychopharmacol; 2017 Jul; 32(4):. PubMed ID: 28568608
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Flibanserin for Low Sexual Desire in Women: A Molecule From Bench to Bed?
    Basson R; Driscoll M; Correia S
    EBioMedicine; 2015 Aug; 2(8):772-3. PubMed ID: 26425670
    [No Abstract]   [Full Text] [Related]  

  • 55. JAMA PATIENT PAGE. Flibanserin for Treating Low Sexual Desire in Women.
    Jin J
    JAMA; 2015 Sep 22-29; 314(12):1312. PubMed ID: 26393863
    [No Abstract]   [Full Text] [Related]  

  • 56. Margaret McCartney: Flibanserin for low sexual desire is not feminism.
    McCartney M
    BMJ; 2015 Oct; 351():h5650. PubMed ID: 26502743
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of Alcohol Administered With Flibanserin in Healthy Premenopausal Women: A Randomized, Double-Blind, Single-Dose Crossover Study.
    Simon JA; Clayton AH; Parish SJ; Apfel SC; Millheiser L
    J Sex Med; 2020 Jan; 17(1):83-93. PubMed ID: 31735618
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Why are there no FDA-approved treatments for female sexual dysfunction?
    Nappi RE
    Expert Opin Pharmacother; 2015; 16(12):1735-8. PubMed ID: 26165387
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Circle of Female Sexual Desire-Have We Come a Long Way?
    Katz A
    Nurs Womens Health; 2016; 20(3):235-8. PubMed ID: 27287350
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypoactive Sexual Desire Disorder: Separating Fact from Fiction.
    Clayton AH; Kim DH
    CNS Spectr; 2016 Feb; 21(1):9-11. PubMed ID: 26530295
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.